Atorvastatin prevents hypoxia-induced inhibition of endothelial nitric oxide synthase expression but does not affect heme oxygenase-1 in human microvascular endothelial cells
- 31 July 2006
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 187 (1) , 26-30
- https://doi.org/10.1016/j.atherosclerosis.2006.03.015
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education and Science (PBZ-KBN 096/P05/2004, PBZ-KBN 097/P05/2004, PBZ-KBN 107/P04/2004)
- Pfizer
- Wellcome Trust
This publication has 28 references indexed in Scilit:
- Probucol Protects Against Smooth Muscle Cell Proliferation by Upregulating Heme Oxygenase-1Circulation, 2004
- Simvastatin Induces Heme Oxygenase-1Circulation, 2004
- Class-specific pro-apoptotic effect of statins on human vascular endothelial cellsClinical Research in Cardiology, 2004
- Statins differentially regulate vascular endothelial growth factor synthesis in endothelial and vascular smooth muscle cellsAtherosclerosis, 2003
- All hydrophobic HMG-CoA reductase inhibitors induce apoptotic death in rat pulmonary vein endothelial cellsAtherosclerosis, 2003
- Heme oxygenase-1 induction may explain the antioxidant profile of aspirinBiochemical and Biophysical Research Communications, 2003
- Rapamycin Induces Heme Oxygenase-1 in Human Pulmonary Vascular CellsCirculation, 2003
- HMG-CoA Reductase Inhibitors Regulate Inflammatory Transcription Factors in Human Endothelial and Vascular Smooth Muscle CellsArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Inhibition of 3-Hydroxy-3-methylglutaryl (HMG)-CoA Reductase Blocks Hypoxia-mediated Down-regulation of Endothelial Nitric Oxide SynthaseJournal of Biological Chemistry, 1997
- Multiple-dose pharmacokinetics, pharmacodynamics, and safety of atorvastatin, an inhibitor of HMG-CoA reductase, in healthy subjectsClinical Pharmacology & Therapeutics, 1996